LIPD Insider Trading Activity and SEC Form 4 Filings
LIPD insider trading summary
No open-market insider purchases or sales of Lipid Sciences Inc/ (LIPD) have been reported on SEC Form 4 in the past 12 months.
Latest LIPD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2008 | Bosko Djordjevic | Director | Buy | $29K (60,000 @ $0.48) |
| May 14, 2008 | Bosko Djordjevic | Director | Buy | $30K (50,000 @ $0.60) |
| Mar 27, 2008 | Ra Capital Management, LLC | 10% Owner | Buy | $11K (8,650 @ $1.30) |
| Mar 27, 2008 | Peter Kolchinsky | 10% Owner | Buy | $11K (8,650 @ $1.30) |
| Mar 27, 2008 | RA Capital Biotech Fund II, L.P. | 10% Owner | Buy | $11K (8,650 @ $1.30) |
| Mar 27, 2008 | RA Capital Biotech Fund LP | 10% Owner | Buy | $11K (8,650 @ $1.30) |
| Mar 27, 2008 | Richard Aldrich | 10% Owner | Buy | $11K (8,650 @ $1.30) |
| Jun 11, 2007 | Bosko Djordjevic | Director | Buy | $83K (50,000 @ $1.66) |
| Jun 11, 2007 | Gary S Roubin | Director | Buy | $64K (46,051 @ $1.40) |
| Jun 11, 2007 | Gary S Roubin | Director | Buy | $6K (3,949 @ $1.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.